Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04314713 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Intramuscular Administration of Scopolamine
A Phase 1 study, sponsored by Battelle Memorial Institute.
- Terminated
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT04314713: Clinical Trial Phase 1 study, sponsored by Battelle Memorial Institute.
NCT04314713 is a Phase 1 study that was terminated before completion, run by Battelle Memorial Institute. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04314713, a Phase 1 study, was terminated before completion, sponsored by Battelle Memorial Institute.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
To characterize the safety and tolerability profile of ascending doses of scopolamine hydrobromide trihydrate (Scopolamine HBT) administered by intramuscular (IM) injection. And characterize the pharmacokinetics (PK) of ascending doses of Scopolamine HBT administered by IM injection
Primary Outcome
Safety and tolerability profile of ascending doses of scopolamine hydrobromide trihydrate (Scopolamine HBT) administered by intramuscular (IM) injection
Interventions
- DRUG Scopolamine Hydrobromide Trihydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-06-02 |
| Est. Completion | 2021-05-06 |
| Phase | Phase 1 |
Why NCT04314713 stopped before completion
NCT04314713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which Scopolamine Hydrobromide Trihydrate is the first listed.
NCT04314713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04314713 about?
NCT04314713 is a clinical study titled "A Study to Evaluate the Intramuscular Administration of Scopolamine". To characterize the safety and tolerability profile of ascending doses of scopolamine hydrobromide trihydrate (Scopolamine HBT) administered by intramuscular (IM) injection. And characterize the pharmacokinetics (PK) of ascending doses of Scopolamine HBT administered by IM injection
What is the current status of trial NCT04314713?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2020-06-02. Estimated completion is 2021-05-06.
What interventions are being tested in trial NCT04314713?
The interventions under investigation include: Scopolamine Hydrobromide Trihydrate (DRUG).
Who is sponsoring clinical trial NCT04314713?
This trial is sponsored by Battelle Memorial Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04314713's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI